Autopsy report · NCT02384746
Phase I Study of the Combination of MLN9708 and Fulvestrant
Cause of deathSlow enrollment
“Low accrual”
Life of this trial
- Registered 6 months before it started.
- Ran for about 3 years before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- Fulvestrant; MLN9708
- Participants
- 9
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.